lol... a "new and improved application"... huh? you mean, they will go through all 3 phases of trials again? on a drug that doesn't work? typical CLSN investor... dumb.
Sorry, my friend, but listen to the conference call again. “I don't believe the data will support (marketing) registration in any of the major markets,” Celsion Chief Executive Michael Tardugno stated.